Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy

Summary: Drug resistance significantly limits the efficacy of chemotherapy. The DNA mismatch repair (MMR) system maintains genomic stability by correcting DNA errors. During DNA-damaging treatments, cancer cells transiently increase their adaptive mutability, also known as microsatellite instability...

Full description

Saved in:
Bibliographic Details
Main Authors: Lianhui Sun, Guangjian Fan, Zhuqing Zhang, Dong Chang, Xiaoyu Zhang, Tongqing Zhang, Jichuan Geng, Xiaoxia Zhang, Menghan Lin, Chen Hu, Jiaqi Zhou, Mengxue Wang, Liu Cao, Mary Zhang, Baokun He, Shengping Zhang, Chuangui Wang
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124725000403
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087831323869184
author Lianhui Sun
Guangjian Fan
Zhuqing Zhang
Dong Chang
Xiaoyu Zhang
Tongqing Zhang
Jichuan Geng
Xiaoxia Zhang
Menghan Lin
Chen Hu
Jiaqi Zhou
Mengxue Wang
Liu Cao
Mary Zhang
Baokun He
Shengping Zhang
Chuangui Wang
author_facet Lianhui Sun
Guangjian Fan
Zhuqing Zhang
Dong Chang
Xiaoyu Zhang
Tongqing Zhang
Jichuan Geng
Xiaoxia Zhang
Menghan Lin
Chen Hu
Jiaqi Zhou
Mengxue Wang
Liu Cao
Mary Zhang
Baokun He
Shengping Zhang
Chuangui Wang
author_sort Lianhui Sun
collection DOAJ
description Summary: Drug resistance significantly limits the efficacy of chemotherapy. The DNA mismatch repair (MMR) system maintains genomic stability by correcting DNA errors. During DNA-damaging treatments, cancer cells transiently increase their adaptive mutability, also known as microsatellite instability (MSI), to evade therapeutic pressure through MMR downregulation, conferring drug resistance. However, an understanding of the underlying mechanisms of MMR protein downregulation under DNA-damaging drugs remains limited. Our study reveals a negative correlation between SIRT7 protein levels and MMR core protein MSH2 levels in cervical and lung cancer tissues. SIRT7 destabilizes MSH2, promoting MSI and mutagenesis. Molecularly, DNA damage triggers ATM kinase-dependent phosphorylation and subcellular redistribution of SIRT7. Phosphorylated SIRT7 interacts with and deacetylates MSH2, impairing MMR, and inducing MSI and drug resistance. Our findings suggest that SIRT7 drives MMR downregulation under therapeutic stress and that ATM-dependent phosphorylation of SIRT7 may serve as a predictive biomarker for chemotherapeutic efficacy and a target for cancer treatment.
format Article
id doaj-art-cbe21f51cba243b780ebb50b4332b440
institution Kabale University
issn 2211-1247
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj-art-cbe21f51cba243b780ebb50b4332b4402025-02-06T05:11:32ZengElsevierCell Reports2211-12472025-02-01442115269Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapyLianhui Sun0Guangjian Fan1Zhuqing Zhang2Dong Chang3Xiaoyu Zhang4Tongqing Zhang5Jichuan Geng6Xiaoxia Zhang7Menghan Lin8Chen Hu9Jiaqi Zhou10Mengxue Wang11Liu Cao12Mary Zhang13Baokun He14Shengping Zhang15Chuangui Wang16Biomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, ChinaHealth Sciences Institute, College of Basic Medical Sciences, China Medical University, Shenyang 110122, ChinaDepartment of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R., Detroit, MI 48201, USAInstitute of Chinese Materia Medica, The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518033, ChinaBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, China; Corresponding authorBiomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, China; Corresponding authorSummary: Drug resistance significantly limits the efficacy of chemotherapy. The DNA mismatch repair (MMR) system maintains genomic stability by correcting DNA errors. During DNA-damaging treatments, cancer cells transiently increase their adaptive mutability, also known as microsatellite instability (MSI), to evade therapeutic pressure through MMR downregulation, conferring drug resistance. However, an understanding of the underlying mechanisms of MMR protein downregulation under DNA-damaging drugs remains limited. Our study reveals a negative correlation between SIRT7 protein levels and MMR core protein MSH2 levels in cervical and lung cancer tissues. SIRT7 destabilizes MSH2, promoting MSI and mutagenesis. Molecularly, DNA damage triggers ATM kinase-dependent phosphorylation and subcellular redistribution of SIRT7. Phosphorylated SIRT7 interacts with and deacetylates MSH2, impairing MMR, and inducing MSI and drug resistance. Our findings suggest that SIRT7 drives MMR downregulation under therapeutic stress and that ATM-dependent phosphorylation of SIRT7 may serve as a predictive biomarker for chemotherapeutic efficacy and a target for cancer treatment.http://www.sciencedirect.com/science/article/pii/S2211124725000403CP: Molecular biologyCP: Cancer
spellingShingle Lianhui Sun
Guangjian Fan
Zhuqing Zhang
Dong Chang
Xiaoyu Zhang
Tongqing Zhang
Jichuan Geng
Xiaoxia Zhang
Menghan Lin
Chen Hu
Jiaqi Zhou
Mengxue Wang
Liu Cao
Mary Zhang
Baokun He
Shengping Zhang
Chuangui Wang
Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
Cell Reports
CP: Molecular biology
CP: Cancer
title Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
title_full Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
title_fullStr Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
title_full_unstemmed Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
title_short Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
title_sort phosphorylation of sirt7 by atm causes dna mismatch repair downregulation and adaptive mutability during chemotherapy
topic CP: Molecular biology
CP: Cancer
url http://www.sciencedirect.com/science/article/pii/S2211124725000403
work_keys_str_mv AT lianhuisun phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT guangjianfan phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT zhuqingzhang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT dongchang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT xiaoyuzhang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT tongqingzhang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT jichuangeng phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT xiaoxiazhang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT menghanlin phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT chenhu phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT jiaqizhou phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT mengxuewang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT liucao phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT maryzhang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT baokunhe phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT shengpingzhang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy
AT chuanguiwang phosphorylationofsirt7byatmcausesdnamismatchrepairdownregulationandadaptivemutabilityduringchemotherapy